UK-CAB 73: IAS feedback, Janssen company meeting

Friday 17 and 24 July 2020

  • Registration
  • Meeting on  Zoom – details to follow
  • Expenses


Part 1: Company meeting with Janssen: 17 July 2020 – 1000-1200hrs
Part 2: IAS feedback 24 July 2020 – 1000-1200hrs

Registration for the meetings is here:

Slides and meeting report (to follow)

Background reading (follow)

Financial support

The UK-CAB receives unrestricted funding from some pharmaceutical companies towards the direct costs of holding four meetings each year.

This funding supports the travel and accommodation costs for members to attend from outside London, plus the cost of catering. The content, programme and agenda for meetings is decided by the UK-CAB steering group in consultation with the wider membership. Funding is unconnected to meeting content.

Companies that develop and market medicines have a responsibility to actively engage with advocacy organisations. HIV positive people and their advocates should also be able to ask manufacturers directly about the safety and efficacy of their products. We should be involved in their proposals for future research.

For a list of companies that support the UK-CAB please see the “about us” page.

This entry was posted in Meetings, News. Bookmark the permalink. Comments are closed, but you can leave a trackback: Trackback URL.